Literature DB >> 22466836

Successful treatment of duodenal myeloid sarcoma with allogeneic bone marrow transplantation and additional radiotherapy.

Toshinari Yagi1, Jun Ishikawa, Masahumi Takahashi, Yukiko Yamashita, Shinsuke Kusakabe, Tetsuhiro Yoshinami, Hiroaki Masaie, Naotoshi Sugimoto, Hitoshi Yoshida, Fumio Imamura.   

Abstract

Myeloid sarcoma (MS) is a tumor consisting of myeloid blasts that occurs at an anatomical site other than the bone marrow. We report the case of a 38-year-old man with duodenal MS who underwent an allogeneic bone marrow transplant in a non-complete remission (CR) state. After the transplant, residual disease was suspected on a fluorodeoxyglucose positron emission tomography (FDG-PET)/CT scan, and additional radiotherapy resulted in CR, which has been maintained for 21 months. FDG-PET/CT scanning is useful for evaluating residual myeloid sarcoma during the peritransplant period.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466836     DOI: 10.2169/internalmedicine.51.6652

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  Myeloid sarcoma derived from the gastrointestinal tract: A case report and review of the literature.

Authors:  Teng Yu; Genbo Xu; Xiaohua Xu; Jing Yang; Luyin Ding
Journal:  Oncol Lett       Date:  2016-05-04       Impact factor: 2.967

2.  Myeloid sarcoma presenting with leukemoid reaction in a child treated for acute lymphoblastic leukemia.

Authors:  Aylin Canbolat Ayhan; Cetin Timur; Seyma Sonmez; Ebru Zemheri; Asım Yoruk
Journal:  Case Rep Hematol       Date:  2014-09-03

3.  Rare myeloid sarcoma/acute myeloid leukemia with adrenal mass after allogeneic mobilization peripheral blood stem cell transplantation.

Authors:  Ya-Fei Wang; Qian Li; Wen-Gui Xu; Jian-Yu Xiao; Qing-Song Pang; Qing Yang; Yi-Zuo Zhang
Journal:  Cancer Biol Med       Date:  2013-12       Impact factor: 4.248

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.